Ensign Peak Advisors Inc trimmed its stake in shares of Cabot Corporation (NYSE:CBT – Free Report) by 7.5% in the 2nd quarter, HoldingsChannel reports. The firm owned 18,465 shares of the specialty chemicals company’s stock after selling 1,487 shares during the quarter. Ensign Peak Advisors Inc’s holdings in Cabot were worth $1,385,000 at the end of the most recent quarter.
A number of other institutional investors have also recently bought and sold shares of the stock. CWM LLC grew its stake in Cabot by 55.0% during the 1st quarter. CWM LLC now owns 600 shares of the specialty chemicals company’s stock valued at $50,000 after acquiring an additional 213 shares in the last quarter. Mackenzie Financial Corp grew its position in Cabot by 18.3% during the first quarter. Mackenzie Financial Corp now owns 7,840 shares of the specialty chemicals company’s stock valued at $652,000 after purchasing an additional 1,210 shares in the last quarter. Banque Cantonale Vaudoise acquired a new position in Cabot in the 1st quarter valued at approximately $43,000. Natixis Advisors LLC lifted its position in Cabot by 14.0% in the 1st quarter. Natixis Advisors LLC now owns 141,417 shares of the specialty chemicals company’s stock worth $11,757,000 after buying an additional 17,338 shares in the last quarter. Finally, LSV Asset Management boosted its stake in shares of Cabot by 318.0% during the 1st quarter. LSV Asset Management now owns 571,034 shares of the specialty chemicals company’s stock valued at $47,476,000 after buying an additional 434,434 shares during the period. Hedge funds and other institutional investors own 93.18% of the company’s stock.
Analyst Upgrades and Downgrades
CBT has been the subject of several research reports. Mizuho reduced their price target on Cabot from $78.00 to $72.00 and set an “outperform” rating for the company in a report on Monday, November 17th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cabot in a research report on Wednesday, October 8th. Zacks Research downgraded shares of Cabot from a “hold” rating to a “strong sell” rating in a research report on Friday, November 7th. UBS Group cut their price target on shares of Cabot from $82.00 to $65.00 and set a “neutral” rating on the stock in a report on Wednesday, November 5th. Finally, JPMorgan Chase & Co. reduced their price objective on shares of Cabot from $75.00 to $54.00 and set an “underweight” rating for the company in a research note on Friday. One research analyst has rated the stock with a Buy rating, two have assigned a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Reduce” and a consensus price target of $63.67.
Cabot Trading Down 1.7%
Shares of CBT stock opened at $62.69 on Friday. The company has a market capitalization of $3.32 billion, a P/E ratio of 8.19 and a beta of 0.90. Cabot Corporation has a 12-month low of $58.33 and a 12-month high of $115.16. The company has a quick ratio of 1.41, a current ratio of 2.13 and a debt-to-equity ratio of 0.66. The firm has a 50-day moving average price of $68.02 and a 200 day moving average price of $73.95.
Cabot (NYSE:CBT – Get Free Report) last released its earnings results on Monday, November 3rd. The specialty chemicals company reported $1.70 earnings per share for the quarter, missing analysts’ consensus estimates of $1.72 by ($0.02). The firm had revenue of $899.00 million for the quarter, compared to the consensus estimate of $967.02 million. Cabot had a return on equity of 25.68% and a net margin of 11.14%.The company’s revenue was down 10.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.80 EPS. Cabot has set its FY 2026 guidance at 6.000-7.00 EPS. Research analysts forecast that Cabot Corporation will post 7.57 earnings per share for the current fiscal year.
Cabot Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 12th. Stockholders of record on Friday, November 28th will be issued a $0.45 dividend. The ex-dividend date is Friday, November 28th. This represents a $1.80 annualized dividend and a dividend yield of 2.9%. Cabot’s dividend payout ratio (DPR) is presently 29.95%.
About Cabot
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Further Reading
- Five stocks we like better than Cabot
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Power On: Applied Digital’s First AI Data Center Goes Live
- What Does Downgrade Mean in Investing?
- Alphabet: The AI Leader Best Positioned to Dominate 2026
- What is the Dogs of the Dow Strategy? Overview and Examples
- 2 Reasons to Load Up on Fiserv, 1 to Stay Away
Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBT – Free Report).
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.
